We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $38.6B
1-Year Est. Return 45.89%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.57%
5 Year Est. Return
+159.2%
10 Year Est. Return
+646.93%
AUM
$70.7B
AUM Growth
-$3.62B
Cap. Flow
-$5.91B
Cap. Flow %
-8.35%
Top 10 Hldgs %
59.58%
Holding
4,066
New
804
Increased
529
Reduced
573
Closed
911

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$68.6M
2
IBM icon
IBM
IBM
+$62.1M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$60M
4
T icon
AT&T
T
+$56.6M
5
NVDA icon
NVIDIA
NVDA
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 0.87%
2 Financials 0.74%
3 Communication Services 0.59%
4 Consumer Discretionary 0.43%
5 Healthcare 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
1701
Zymeworks
ZYME
$1.73B
$16K ﹤0.01%
1,100
TTOO
1702
DELISTED
T2 Biosystems, Inc
TTOO
0
AKTX
1703
Akari Therapeutics
AKTX
$13.1M
$15K ﹤0.01%
9
CNQ icon
1704
Canadian Natural Resources
CNQ
$93.3B
$15K ﹤0.01%
858
+31
+4% +$525
CVE icon
1705
Cenovus Energy
CVE
$51.1B
$15K ﹤0.01%
1,459
-289
-17% -$2.91K
MEOH icon
1706
Methanex
MEOH
$4.02B
$15K ﹤0.01%
213
+198
+1,320% +$13.3K
NBR icon
1707
Nabors Industries
NBR
$1.16B
$15K ﹤0.01%
47
-122
-72% -$44.8K
R icon
1708
Ryder
R
$10.2B
$15K ﹤0.01%
208
+196
+1,633% +$13.7K
SHW icon
1709
Sherwin-Williams
SHW
$89.7B
$15K ﹤0.01%
108
CPE
1710
DELISTED
Callon Petroleum Company
CPE
$15K ﹤0.01%
141
-35
-20% -$4.34K
ICPT
1711
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$15K ﹤0.01%
+181
New +$13.3K
CATY icon
1712
Cathay General Bancorp
CATY
$4.29B
$14K ﹤0.01%
353
+302
+592% +$12.5K
CHD icon
1713
Church & Dwight Co
CHD
$24.6B
$14K ﹤0.01%
+254
New +$12.3K
TKC icon
1714
Turkcell
TKC
$4.73B
$14K ﹤0.01%
+2,067
New +$15.7K
UL icon
1715
Unilever
UL
$139B
$14K ﹤0.01%
+232
New +$14.4K
WMK icon
1716
Weis Markets
WMK
$1.85B
$14K ﹤0.01%
+261
New +$12.9K
TRHC
1717
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$14K ﹤0.01%
+218
New +$10.7K
ACAD icon
1718
Acadia Pharmaceuticals
ACAD
$4.93B
$13K ﹤0.01%
+842
New +$15K
ARWR icon
1719
Arrowhead Research
ARWR
$12.2B
$13K ﹤0.01%
+975
New +$9.11K
DK icon
1720
Delek US
DK
$3.66B
$13K ﹤0.01%
267
-1,897
-88% -$94.3K
GIL icon
1721
Gildan
GIL
$10.8B
$13K ﹤0.01%
+449
New +$13K
QLYS icon
1722
Qualys
QLYS
$6.45B
$13K ﹤0.01%
151
+134
+788% +$10.8K
STWD icon
1723
Starwood Property Trust
STWD
$6.01B
$13K ﹤0.01%
+583
New +$12.5K
SIVB
1724
DELISTED
SVB Financial Group
SIVB
$13K ﹤0.01%
46
-7,922
-99% -$2.33M
RBC icon
1725
RBC Bearings
RBC
$18.1B
$12K ﹤0.01%
+95
New +$11.8K

Similar funds

Parallax Volatility Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Parallax Volatility Advisers held 4,066 positions worth $70.7B, down 4.9% from $74.4B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Parallax Volatility Advisers withdrew a net $5.91B in Q2 2018, closing 911 positions and reducing 573 holdings. Its most notable exit was Las Vegas Sands, an estimated $49.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 0.87% of assets, down from 0.93% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Parallax Volatility Advisers opened a new position in McKesson worth $24.2M.

  • Parallax Volatility Advisers's largest Q2 2018 buy was McKesson: 181,730 shares worth $24.2M.
  • Parallax Volatility Advisers added most to Citigroup in Q2 2018, an estimated $68.6M increase.
  • Parallax Volatility Advisers's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $195M.
  • Parallax Volatility Advisers fully exited Las Vegas Sands in Q2 2018, selling an estimated $49.2M.
  • Parallax Volatility Advisers's ten largest holdings make up 60% of its $70.7B portfolio in Q2 2018.
  • Parallax Volatility Advisers opened 804 new positions and closed 911 in Q2 2018.
  • Parallax Volatility Advisers's portfolio value fell 4.9% quarter-over-quarter to $70.7B.

Based on Parallax Volatility Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.